Annual Long Term Debt
$504.21 M
+$399.60 M+382.00%
September 30, 2024
Summary
- As of February 7, 2025, ARWR annual long term debt is $504.21 million, with the most recent change of +$399.60 million (+382.00%) on September 30, 2024.
- During the last 3 years, ARWR annual long term debt has risen by +$480.92 million (+2064.46%).
- ARWR annual long term debt is now at all-time high.
Performance
ARWR Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$504.21 M
+$392.17 M+350.03%
September 30, 2024
Summary
- As of February 7, 2025, ARWR quarterly long term debt is $504.21 million, with the most recent change of +$392.17 million (+350.03%) on September 30, 2024.
- Over the past year, ARWR quarterly long term debt has increased by +$390.58 million (+343.72%).
- ARWR quarterly long term debt is now at all-time high.
Performance
ARWR Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
ARWR Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +382.0% | +343.7% |
| 3 y3 years | +2064.5% | +2064.5% |
| 5 y5 years | +100.0% | +2064.5% |
ARWR Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +2064.5% | at high | +2142.0% |
| 5 y | 5-year | at high | -100.0% | at high | +3456.1% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
Arrowhead Pharmaceuticals Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $504.21 M(+382.0%) | $504.21 M(+350.0%) |
| Jun 2024 | - | $112.04 M(-1.4%) |
| Mar 2024 | - | $113.63 M(-1.3%) |
| Dec 2023 | - | $115.16 M(+10.1%) |
| Sep 2023 | $104.61 M(+32.8%) | $104.61 M(+30.9%) |
| Jun 2023 | - | $79.91 M(-0.2%) |
| Mar 2023 | - | $80.07 M(+0.8%) |
| Dec 2022 | - | $79.47 M(+0.9%) |
| Sep 2022 | $78.80 M(+238.3%) | $78.80 M(+0.7%) |
| Jun 2022 | - | $78.23 M(+244.7%) |
| Mar 2022 | - | $22.70 M(+0.9%) |
| Dec 2021 | - | $22.49 M(-3.5%) |
| Sep 2021 | $23.30 M(+16.2%) | $23.30 M(+1.9%) |
| Jun 2021 | - | $22.85 M(+1.4%) |
| Mar 2021 | - | $22.53 M(+14.4%) |
| Dec 2020 | - | $19.68 M(-1.8%) |
| Sep 2020 | $20.04 M(>+9900.0%) | $20.04 M(-1.6%) |
| Jun 2020 | - | $20.36 M(+43.6%) |
| Mar 2020 | - | $14.18 M(-1.4%) |
| Dec 2019 | - | $14.38 M(>+9900.0%) |
| Sep 2019 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2018 | $2.10 M(-9.6%) | $2.10 M(-2.7%) |
| Jun 2018 | - | $2.16 M(-2.6%) |
| Mar 2018 | - | $2.22 M(-2.4%) |
| Dec 2017 | - | $2.27 M(-2.3%) |
| Sep 2017 | $2.33 M(-8.2%) | $2.33 M(-2.2%) |
| Jun 2017 | - | $2.38 M(-2.2%) |
| Mar 2017 | - | $2.43 M(-2.1%) |
| Dec 2016 | - | $2.48 M(-2.0%) |
| Sep 2016 | $2.53 M(+368.5%) | $2.53 M(-14.5%) |
| Jun 2016 | - | $2.96 M(+587.8%) |
| Mar 2016 | - | $430.70 K(-11.3%) |
| Dec 2015 | - | $485.80 K(-10.2%) |
| Sep 2015 | $540.80 K(-28.7%) | $540.80 K(-9.2%) |
| Jun 2015 | - | $595.50 K(-8.4%) |
| Mar 2015 | - | $650.00 K(-7.8%) |
| Dec 2014 | - | $705.20 K(-7.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2014 | $758.30 K(-31.8%) | $758.30 K(-6.6%) |
| Jun 2014 | - | $812.20 K(-6.2%) |
| Mar 2014 | - | $865.80 K(-14.0%) |
| Dec 2013 | - | $1.01 M(-9.4%) |
| Sep 2013 | $1.11 M(-47.6%) | $1.11 M(-4.8%) |
| Jun 2013 | - | $1.17 M(-4.5%) |
| Mar 2013 | - | $1.22 M(-4.3%) |
| Dec 2012 | - | $1.28 M(-39.8%) |
| Sep 2012 | $2.12 M(+249.7%) | $2.12 M(-0.4%) |
| Jun 2012 | - | $2.13 M(-0.4%) |
| Mar 2012 | - | $2.14 M(-0.4%) |
| Dec 2011 | - | $2.15 M(+253.8%) |
| Sep 2011 | $606.80 K(+21.4%) | $606.80 K(+8.2%) |
| Jun 2011 | - | $560.90 K(+7.9%) |
| Mar 2011 | - | $519.70 K(+3.9%) |
| Sep 2009 | $500.00 K(-31.2%) | $500.00 K(-13.0%) |
| Jun 2009 | - | $574.80 K(-79.6%) |
| Mar 2009 | - | $2.81 M(-7.2%) |
| Dec 2008 | - | $3.03 M(+317.1%) |
| Sep 2008 | $726.50 K(+2541.8%) | $726.50 K(+2541.8%) |
| Jun 2003 | - | $27.50 K(0.0%) |
| Mar 2003 | - | $27.50 K(+5.8%) |
| Dec 2002 | - | $26.00 K(-5.5%) |
| Sep 2002 | $27.50 K(-16.7%) | $27.50 K(-5.2%) |
| Jun 2002 | - | $29.00 K(-4.9%) |
| Mar 2002 | - | $30.50 K(-4.7%) |
| Dec 2001 | - | $32.00 K(-3.0%) |
| Sep 2001 | $33.00 K(-15.4%) | $33.00 K(-4.3%) |
| Jun 2001 | - | $34.50 K(-4.2%) |
| Mar 2001 | - | $36.00 K(-4.0%) |
| Dec 2000 | - | $37.50 K(-3.8%) |
| Sep 2000 | $39.00 K(-9.3%) | $39.00 K(-3.7%) |
| Jun 2000 | - | $40.50 K(+3.8%) |
| Mar 2000 | - | $39.00 K(-1.3%) |
| Dec 1999 | - | $39.50 K |
| Sep 1999 | $43.00 K(-4.4%) | - |
| Sep 1998 | $45.00 K | - |
FAQ
- What is Arrowhead Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual long term debt year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly long term debt year-on-year change?
What is Arrowhead Pharmaceuticals annual long term debt?
The current annual long term debt of ARWR is $504.21 M
What is the all time high annual long term debt for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual long term debt is $504.21 M
What is Arrowhead Pharmaceuticals annual long term debt year-on-year change?
Over the past year, ARWR annual long term debt has changed by +$399.60 M (+382.00%)
What is Arrowhead Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of ARWR is $504.21 M
What is the all time high quarterly long term debt for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly long term debt is $504.21 M
What is Arrowhead Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, ARWR quarterly long term debt has changed by +$390.58 M (+343.72%)